Facebook
Twitter
Telegram
Fehler meldenIntercept Pharmaceuticals Bilanz 2011-2024 | ICPT
Bilanz Jährlich Intercept Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
173 M | 455 M | 502 M | 1.04 B | 721 M | 631 M | 943 M | -32.7 M | -20 M | -13.4 M | -45.5 M | -17.6 M |
Langfristige Schulden |
223 M | 540 M | 561 M | 532 M | 371 M | 356 M | 341 M | - | - | - | - | - |
Langfristiger Schuldenstrom |
- | - | - | 6.46 M | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 541 M | 376 M | 364 M | 346 M | 6.24 M | 8.02 M | 59 M | 33.3 M | 18 M |
Kurzfristige Verbindlichkeiten |
230 M | 168 M | 179 M | 162 M | 114 M | 104 M | 78.5 M | 47.4 M | 15.2 M | 8.88 M | 13 M | - |
Gesamtverbindlichkeiten |
461 M | 711 M | 747 M | 703 M | 490 M | 468 M | 424 M | 53.6 M | 23.3 M | 67.9 M | 46.3 M | 22 M |
Aufgeschobenes Einkommen |
- | - | - | - | 1.62 M | 1.78 M | 5.69 M | 1.78 M | 1.78 M | 1.62 M | 1.62 M | 2.45 M |
Gewinnrücklagen |
-2.14 B | -2.49 B | -2.4 B | -2.12 B | -1.78 B | -1.47 B | -1.11 B | -696 M | -469 M | -186 M | -118 M | -74.5 M |
Vermögenswerte |
554 M | 527 M | 580 M | 755 M | 509 M | 484 M | 739 M | 656 M | 254 M | 150 M | 112 M | 19.5 M |
Zahlungsmittel |
50.5 M | 84.7 M | 58.2 M | 70.1 M | 43.2 M | 70 M | 43.7 M | 32.7 M | 20 M | 13.4 M | 45.5 M | 17.7 M |
Buchwert |
93.1 M | -184 M | -167 M | 51.6 M | 19.1 M | 16.4 M | 315 M | 602 M | 231 M | 82.4 M | 65.9 M | -2.56 M |
Gesamtes Eigenkapital |
93.1 M | -184 M | -167 M | 51.6 M | 19.1 M | 16.4 M | 315 M | 602 M | 231 M | 82.4 M | 65.9 M | -2.56 M |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Intercept Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
224 M | 224 M | 223 M | 223 M | 223 M | - | 717 M | 540 M | 530 M | 576 M | 568 M | 561 M | 561 M | 561 M | 561 M | 532 M | 532 M | 532 M | 532 M | 371 M | 371 M | 371 M | 371 M | 356 M | 356 M | 356 M | 356 M | 341 M | 341 M | 341 M | 341 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
321 M | 417 M | 437 M | 461 M | 452 M | - | 875 M | 711 M | 679 M | 726 M | 720 M | 747 M | 747 M | 747 M | 747 M | 703 M | 703 M | 703 M | 703 M | 490 M | 490 M | 490 M | 490 M | 468 M | 468 M | 468 M | 468 M | 424 M | 424 M | 424 M | 424 M | 53.6 M | 53.6 M | 53.6 M | 53.6 M | 23.3 M | 23.3 M | 23.3 M | 23.3 M | 67.9 M | 67.9 M | 67.9 M | 67.9 M | 46.3 M | 46.3 M | 46.3 M | 46.3 M | 22 M | 22 M | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.22 M | 1.62 M | 2.72 M | 1.62 M | 1.62 M | 1.62 M | 1.62 M | 1.78 M | 1.78 M | 1.78 M | 1.78 M | 5.69 M | 5.69 M | 5.69 M | 5.69 M | 1.78 M | 1.78 M | 1.78 M | 1.78 M | 1.78 M | 1.78 M | 1.78 M | 1.78 M | 1.62 M | 1.62 M | 1.62 M | 1.62 M | 1.62 M | 1.62 M | 1.62 M | 1.62 M | 2.45 M | 2.45 M | - | - |
Gewinnrücklagen |
-2.18 B | -2.17 B | -2.17 B | -2.14 B | -2.12 B | - | -2.38 B | -2.49 B | -2.45 B | -2.45 B | -2.44 B | -2.4 B | -2.4 B | -2.4 B | -2.4 B | -2.12 B | -2.12 B | -2.12 B | -2.12 B | -1.78 B | -1.78 B | -1.78 B | -1.78 B | -1.47 B | -1.47 B | -1.47 B | -1.47 B | -1.11 B | -1.11 B | -1.11 B | -1.11 B | -696 M | -696 M | -696 M | -696 M | -469 M | -469 M | -469 M | -469 M | -186 M | - | -186 M | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
393 M | 485 M | 504 M | 554 M | 559 M | - | 503 M | 527 M | 523 M | 523 M | 520 M | 580 M | 580 M | 580 M | 580 M | 755 M | 755 M | 755 M | 755 M | 509 M | 509 M | 509 M | 509 M | 484 M | 484 M | 484 M | 484 M | 739 M | 739 M | 739 M | 739 M | 656 M | 656 M | 656 M | 656 M | 254 M | 254 M | 254 M | 254 M | 150 M | 150 M | 150 M | 150 M | 112 M | 112 M | 112 M | 112 M | 19.5 M | 19.5 M | - | - |
Zahlungsmittel |
103 M | 136 M | 61.4 M | 50.5 M | 113 M | 58 M | 48.3 M | 84.7 M | 68.3 M | 146 M | 92.9 M | 58.2 M | 58.2 M | 58.2 M | 58.2 M | 70.1 M | 70.1 M | 70.1 M | 70.1 M | 43.2 M | 43.2 M | 43.2 M | 43.2 M | 70 M | 70 M | 70 M | 70 M | 43.7 M | 43.7 M | 43.7 M | 43.7 M | 32.7 M | 32.7 M | 32.7 M | 32.7 M | 20 M | 20 M | 20 M | 20 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 45.5 M | 45.5 M | 45.5 M | 45.5 M | 17.7 M | 17.7 M | - | - |
Buchwert |
71.8 M | 67.5 M | 67.2 M | 93.1 M | 108 M | - | -372 M | -184 M | -156 M | -203 M | -200 M | -167 M | -167 M | -167 M | -167 M | 51.6 M | 51.6 M | 51.6 M | 51.6 M | 19.1 M | 19.1 M | 19.1 M | 19.1 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 315 M | 315 M | 315 M | 315 M | 602 M | 602 M | 602 M | 602 M | 231 M | 231 M | 231 M | 231 M | 82.4 M | 82.4 M | 82.4 M | 82.4 M | 65.9 M | 65.9 M | 65.9 M | 65.9 M | -2.56 M | -2.56 M | - | - |
Gesamtes Eigenkapital |
71.8 M | 67.5 M | 67.2 M | 93.1 M | 108 M | -370 M | -372 M | -184 M | -156 M | -203 M | -200 M | -167 M | -167 M | -167 M | -167 M | 51.6 M | 51.6 M | 51.6 M | 51.6 M | 19.1 M | 19.1 M | 19.1 M | 19.1 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 315 M | 315 M | 315 M | 315 M | 602 M | 602 M | 602 M | 602 M | 231 M | 231 M | 231 M | 231 M | 82.4 M | 82.4 M | 82.4 M | 82.4 M | 65.9 M | 65.9 M | 65.9 M | 65.9 M | -2.56 M | -2.56 M | - | - |
Alle Zahlen in USD-Währung